Form D · Pharmaceuticals
Atlas US Royalty LLC
Mountain View, CA · CIK 0001603018
Offering snapshot reported Mar 28, 2014 · SEC filing
- Reported sold
- $45M Offering amount: $45M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $250K Reported outside-investor minimum
- First sale
- Mar 18, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 28, 2014 | Initial | $45,000,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $3M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-214508
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Morgan Stanley & Co. LLC | 8209 | Morgan Stanley & Co. LLC · CRD 8209 |
Source: Form D, filed Mar 28, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Alexza Pharmaceuticals, Inc. | Promoter |
| Orlando C. Figueroa | Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2091 Stierlin Court
Mountain View, CA, 94043
Mountain View, CA, 94043